A disfiguring and fatal case of mucormycosis after dexamethasone treatment for a COVID-19 infection

Abstract

This case report describes a patient with uncontrolled type 2 diabetes mellitus who received steroids for an outpatient infection of COVID-19. The steroid course combined with his acute illness likely contributed to his development of extremely high blood sugar levels (790 mg/dL) and subsequent hyperosmolar hyperglycemic syndrome. In this compromised state, he contracted invasive mucormycosis of the right sinuses and right orbit. This fungal infection caused him to lose his eye and, later, his life. Prescribing systemic steroids comes with many risks. Providers must be careful to use them only when absolutely indicated, especially in patients who are vulnerable to complications, such as those with uncontrolled type 2 diabetes. This case is a grim example of the dangers that can occur with systemic steroid usage.

Downloads

Download data is not yet available.
Published
2023-04-25
How to Cite
Guerin, C., Pederson, A., Chaudhury, T., Freedman, K., & Ray, C. (2023). A disfiguring and fatal case of mucormycosis after dexamethasone treatment for a COVID-19 infection. The Southwest Respiratory and Critical Care Chronicles, 11(47), 42-46. https://doi.org/10.12746/swrccc.v11i47.1143